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Myrciaria cauliflora is a functional food rich in anthocyanins, possessing antioxidative and
anti-inflammatory properties. Our previous results demonstrated M. cauliflora extract
(MCE) had beneficial effects in diabetic nephropathy (DN) and via the inhibition of Ras/
PI3K/Akt and kidney fibrosis-related proteins. The purpose of this study was to assess the
benefit of MCE in diabetes associated with kidney inflammation and glycemic regulation
in streptozotocinenicotinamide (STZ/NA)-induced diabetic mice. Compared with the
untreated diabetic group, MCE significantly improved blood glucose and serum
biochemical characteristic levels. Exposure to MCE increased antioxidative enzyme ac-
tivity and diminished reactive oxygen synthesis. Mice receiving MCE supplementation
had reduced intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion
molecule-1 (VCAM-1), monocyte chemoattractant protein 1 (MCP-1), colony stimulating
factor 1 (CSF-1), interleukin-1b (IL-1b), IL-6 and tumor necrosis factor a (TNF-a) levels
compared to the untreated diabetic mice. Inflammatory and fibrotic related proteins such
as collagen IV, fibronectin, Janus kinase (JAK), phosphorylated signal transducer and
activator of transcription 3 (STAT3), protein kinase C beta (PKC-b), and nuclear factormistry and Biotechnology, Chung Shan Medical University, 110, Section 1, Jianguo North
Wang); Department of Biochemistry, School of Medicine, Chung Shan Medical University,
strict, Taichung, Taiwan (H.-P. Huang).
. Huang).
inistration, Taiwan. Published by Elsevier Taiwan LLC. This is an open access article under the CC
/licenses/by-nc-nd/4.0/).
j o u r n a l o f f o o d and d ru g an a l y s i s 2 4 ( 2 0 1 6 ) 7 3 0e7 3 7 731kappa B (NF-kB) were also inhibited by MCE treatment in STZ/NA mice. These results
suggest that MCE may be used as a hypoglycemic agent and antioxidant in Type 2 dia-
betic mice.
Copyright © 2016, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Diabetes mellitus (DM) is a chronic metabolic disorder char-
acterized by hyperglycemia. Diabetic nephropathy (DN), a
diabetic complication, is the leading cause of end-stage renal
disease and is a growing global health problem [1,2]. Despite
developments in pharmacological strategies to modulate
diabetes, DN remains a major microvascular complication in
many patients with diabetes. However, there is still insuffi-
cient understanding of the full mechanism involved in pro-
gressive diabetic renal disease.
Persistent hyperglycemia is accountable for the damages
of various organs and tissues in diabetic patients. However,
diabetic complications are not merely due to hyperglycemia.
Previous investigations from DN patients and animals have
indicated that oxidative stress and inflammation induced by
hyperglycemia and dyslipidemia play significant roles in the
development of vascular complications such as cardiomyop-
athy and nephropathy [3e7]. Hyperglycemia in diabetic pa-
tients leads to mitochondrial dysfunction, advanced glycation
end processes and other factors, and generate the reactive
free radicals, then triggers the fragmentation of DNA, which
results in apoptotic cell death [8,9]. Hyperglycemia also causes
oxidative stress, decreases the regeneration of glutathione
(GSH) from oxidized GSH and reduces the availability of
nicotinamide adenine dinucleotide phosphate [10,11]. These
superactive radicals may also interfere with the expressions
of several transcription proteins such as nuclear factor kappa
B (NF-kB), protein kinases C (PKCs), and caspases [3]. On the
other hand, the development of DN is associated with signif-
icant inflammatory cell infiltration and increased plasma
levels of C-reactive protein and inflammatory cytokines, such
as vascular cell adhesion molecule-1 (VCAM-1), tumor ne-
crosis factor a (TNF-a), interleukin 6 (IL-6) and IL-1b [3,12,13].
Oxidative stress and inflammation are inseparably linked, as
each begets and amplifies the other. Therefore, it is important
to counteract diabetic pathophysiology throughmultitargeted
therapeutic agents. Hence, therapies targeting oxidative
stress and inflammation may effectively preserve normal
renal function and prevent or slow the progression of DN.
Many functional foods have been identified as effective
therapeutic agents for metabolic disorders such as obesity,
diabetes, and its complications [14]. Polyphenol-rich foods
have been recognized as important dietary sources of antiox-
idants for human health. They have also attracted attention as
functional foods with various bioactivities, for instance, anti-
viral, antimicrobial, antimutagenic and anticancer activities
[15e17]. Jaboticaba (Myrciaria cauliflora) is a native fruit with
interesting nutritional properties from the Brazilian Atlantic
Forest, and is rich inminerals, fibers, and phenolics, especially
anthocyanins [18e20]. Jaboticaba is reported in popularmedicine as an astringent, and is useful against diarrhea, skin
irritations, gut inflammation, increasing high-density lipopro-
tein, and improving insulin resistance in rats in a diet-induced
obesity model [19e21]. We have determined the effects of MCE
intake in streptozotocinenicotinamide (STZ/NA) mice fed a
high-fat diet recently [22]. This study is to further evaluate if
MCE could offer a prophylactic role against DN through inhib-
iting oxidative stress and inflammatory response.2. Method
2.1. Preparation of MCE
The lyophilized fruit of M. cauliflora Berg from the Modern
Garden Jabuticaba Co. Ltd, Changhua, Taiwan (100 g) were
macerated and stirred with water (100 mL), and the juice was
then filtered and centrifuged (10,000g, 15 min). The MCE was
obtained after being filtered and concentrated under reduced
pressure at 30C and stored at 20C before use.2.2. Experimental animals
All procedures involving animals were approved by the
guidelines of IACUC (Institutional Animal Care and Use
Committee) of CSMU (Animal Center of Chung Shan Medical
University). Five- to six-week male C57BL/6 mice were accli-
matized for 7 days, then randomly divided into nondiabetic
and diabetic groups, and allowed to take food and water ad
libitum before any food-related treatment began. Non-obese
Type 2 diabetes mice were fasted for 16 hours before
receiving the chemicals. STZ dissolved in a 50 mM citric acid
buffer was administered at 100 mg/kg by intraperitoneal in-
jection twice on Days 0 and 2. NA was dissolved in saline and
administered at 240 mg/kg by intraperitoneal injection 15
minutes before the administration of STZ on Day 1. The
nondiabetic mice were injected with citrate buffer or saline
alone. A modified high-fat diet (5 g/day per mouse) was used
to induce Type 2 diabetes in the STZ/NA mice [23]. Animals
were divided into five groups of 10 mice, each as follows:
 Control group: Normal mice were given a control diet daily
for 8 weeks.
 STZ/NA group: STZ/NA treated mice were given a high-fat
diet daily for 8 weeks.
 STZ/NAþ 0.1% MCE group: STZ/NA treated mice were
given a high-fat diet daily with 0.1 % MCE for 8 weeks.
 STZ/NAþ 0.5% MCE group: STZ/NA treated mice were
given a high-fat diet daily with 0.5 % MCE for 8 weeks.
 STZ/NAþ 1.0% MCE group: STZ/NA treated mice were
given a high-fat diet daily with 1.0 % MCE for 8 weeks.
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clean metabolic cages 1 day before sacrifice, and urine was
collected for 24 hours. Then, the mice were sacrificed and the
kidney, blood, and urine were isolated for analysis.
2.3. Kidney biochemical analysis
The kidney was excised, cleaned and washed with ice-cold
saline (pH 7.4). It was then homogenized in TriseHCl
(0.1 M)-EDTA buffer (pH 7.4, 0.001 M) and centrifuged at
12,000g for 30 min at 4C, and the supernatant was collected
to detect the oxidative stress. The intracellular reactive oxy-
gen species (ROS) production was measured modified by the
method of LeBel and Bondy [24]. 20,70-Dichloro-fluorescein
formation which was oxidized in the presence of ROS was
measured by fluorescence spectrometer (Hitachi; Tokyo,
Japan) set at an excitation wavelength of 488 nm and emis-
sion wavelength of 510 nm. o-Phthalaldehyde was used as a
reagent for a fluorometric assay of GSH. After incubating the
sample with o-phthalaldehyde at room temperature for 15
minutes, the solution was transferred to a quartz cuvette.
Fluorescence at 420 nm was determined with the activation
at 350 nm. Activity of antioxidant enzymes such as catalase
(CAT), superoxide dismutase, and glutathione peroxidase
was estimated by the methods reported by Ghosh et al [25].
2.4. Assay of inflammatory cytokines
Concentrations of inflammatory cytokines (IL-1b, IL-6, TNF-a)
in renal tissue samples were analyzed by enzyme-linked
immunosorbent assay. A SpectraMax Plus 384 Microplate
Reader (Molecular Devices LLC; California, USA) was used for
the measurement of optical density.
2.5. RNA isolation and real-time quantitative
polymerase chain reaction (RT-PCR)
Total RNA was isolated from kidney tissues using an RNA
isolation kit (Ultraspec, Biotecx Laboratories; Houston, TX,
USA) according to the manufacturer's protocol and wasTable 1 e Sequences of reverse transcription-polymerase chai
Gene Name
ICAM-1
VCAM-1
MCP-1
CSF-1
TNF-a
IL-1b
IL-6
b-Actinquantified spectrophotometrically by measuring the absor-
bance of an aliquot at 260 nm. The RNA samples were reverse
transcribed into cDNA using a High-capacity cDNA reverse
transcription kit (PE Applied Biosystems; Foster City, CA,
USA). The primers used for RT-PCR were as in Table 1. RT-
PCR was carried out in triplicate using the GeneAmp PCR
System 2700 (Applied Biosystems). The amount of mRNA was
calculated by the comparative CT method, which depends on
the ratio of the amount of target genes to reference gene b-
actin.
2.6. Immunohistochemistry for CD68 detection
Kidneys were fixed in 4% paraformaldehyde solution and
embedded in paraffin. After deparaffinization and rehydra-
tion, 5-mm kidney sections were treated with 3% H2O2 for 10
minutes and with 1% bovine serum albumin in phosphate
buffered saline for 30 minutes. These samples were incubated
overnight at 4C with anti-CD68 antibody (1:200) and then
incubated with secondary antibody for 1 hour at room tem-
perature. After staining the nucleus with hematoxylin for 5
minutes, the images were viewed under a Nikon Eclipse E600
microscopy system (400 amplification; Nikon Instruments
Inc., Melville, NY, USA). Score of CD68 was determined by
quantitative image analysis software (Pax-it, Paxcam; Villa
Park, IL, USA).
2.7. Western blotting assay
Renal tissues were homogenized in lysis buffer. Proteins were
collected by centrifugation at 12,000g and 4C. The total pro-
tein samples were run on 8e12% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis, transferred onto nitro-
cellulose membranes and incubated in blocking buffer (5%
milk and 0.5% bovine serum albumin) for 1 hour at room
temperature and then incubated overnight at 4C with the
primary antibodies. After three washes with Tris-buffered
saline containing 0.05% Tween 20 (TBST), membranes were
incubated with secondary horseradish peroxidase-conjugated
antibody for 1 hour at room temperature. Antigeneantibodyn reaction primers.
Sequence
Forward, 50-GTGATGGCAGCCTCTTATGT-30
Reverse, 50-GGGCTTGTCCCTTGAGTTT-30
Forward, 50-GATACAACCGTCTTGGTCAGCCC-30
Reverse, 50-CAGTTGAAGGATGCGGGAGTATATG-30
Forward, 50-CCACTCACCTGCTGCTACTCAT-30
Reverse, 50-TGGTGATCCTCTTGTAGCTCTCC-30
Forward, 50-GCT GTTGTTGGTCTGTCTC-30
Reverse, 50-CATGCTCTTCATAATCCTT G-30
Forward, 50-CTACCTTGTTGCCTCCTCTTT-30
Reverse, 50-GAGCAGAGGTTCAGTGATGTAG-30
Forward, 50-AACCTGCTGGTGTGTGACGTTC-30
Reverse, 50-CAGCACGAGGCTTTTTTGTTGT-30
Forward, 50-ACAACCACGGCCTTCCCTACTT-30
Reverse, 50-CACGATTTCCCAGAGAACATGTG-30
Forward, 50-AGGTATCCTGA CCCTGAAGTA-30
Reverse, 50-CACACGCAGCTCATTGTAGA-30
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chemiluminescence kit (Millipore, St. Louis, Missouri, USA)
and analyzed using AlphaImager Series 2200 software (Alpha
Innotech; San Leandro, CA, USA).2.8. Statistical analysis
Data was collected from 10 mice in each group, and the re-
sults are presented as means ± SD. The difference among the
three groups (control, STZ/NA-induced, and MCE groups)
was analyzed using one-way ANOVA. The difference be-
tween the two groups was analyzed using the Student t-test
performed with Sigmaplot software (Microsoft Windows,
version 12). Statistical significance was detected at the 0.05
level.3. Results
3.1. MCE prevented kidney oxidative stress in STZ/NA
mice
Oxidative stress is considered as themain pathogenesis of DN
closely associatedwith hyperglycemia and hyperlipidemia [4].
We also examined the biochemical characteristics of STZ/NA
mice and the antihyperglycemic and antihyperlipidemic ef-
fects of MCE were similar to our previous study (data not
shown) [22]. To demonstrate the antioxidant effect of MCE
against renal damage, oxidative damage in the kidney was
assessed and showed in Table 2. The ROS production in the
STZ/NA group was found to be significantly higher than in the
control group. The first line of cellular defense against
oxidative stress including thiol-base antioxidant system (GSH)
and antioxidant enzymes such as catalase, superoxide dis-
mutase, glutathione-S-transferase and glutathione peroxi-
dase were measured here [26,27]. In this study, STZ/NA-
induced mice were showed an obvious depletion in GSH and
antioxidant enzymes in renal tissue. Excessive ROS genera-
tion decreases the activities of these enzymes in Type 2 dia-
betes. Importantly, treatment with MCE reduced oxidant
damage in the kidneys of STZ/NAmice. The extract may have
a prophylactic effect against oxidative stress and associated
renal dysfunction of Type 2 diabetes.Table 2 e Antioxidant effect of MCE on serum biochemical cha
Control STZ
ROS production (nmol/min/mg of protein) 35.54 ± 2.25 78.24 ±
GSH (mg/g of tissue) 23.24 ± 2.11 14.87 ±
CAT (U/mg of protein) 234.22 ± 15.79 144.87 ±
SOD (U/mg of protein) 145.94 ± 6.58 91.66 ±
GST (mmol/min/mg of protein) 0.82 ± 0.08 0.44 ±
GPx (nmol/min/mg of protein) 69.39 ± 5.25 39.67 ±
CAT¼ catalase; GSH¼ glutathione; GST¼ glutathione-S-transferase;
ROS¼ reactive oxygen species; SOD¼ superoxide.
Data are presented as mean ± SD; n¼ 10 mice per group.
* p < 0.05, ** p < 0.001 significant difference compared to the control group
*** p < 0.05, **** p< 0.001 significant difference compared to the STZ/NA gr3.2. MCE reduced the inflammatory gene expression and
inflammatory cell infiltration in the kidney of STZ/NA mice
In addition to oxidative stress, hyperglycemia and hyperlip-
idemia in Type 2 diabetes induce renal damage associated
with the severe inflammation characterized by the release of
various inflammatory factors. Up-regulated ICAM-1 (Icam1),
VCAM-1 (Vcam1), MCP-1 (Mcp-1), CSF-1 (Csf-1), TNF-a (Tnf-a),
IL-1b (Il-1b) and IL-6 (Il-6) expression were found in STZ/NA
mice. The increased mRNA level in these factors was sup-
pressed by treatmentwithMCE (Fig. 1). Immunohistochemical
staining for CD68 was assayed in kidney tissue samples. STZ/
NA mice showed increased infiltration of CD68-positive
(CD68þ) macrophages in interstitial areas and no macro-
phage was found in the control kidney. MCE reduced renal
CD68þmacrophage infiltration in STZ/NA mice (Fig. 2).3.3. Treatment with MCE modulated the renal fibrosis of
STZ/NA mice
NF-kB plays an integral role in the regulation of various in-
flammatory and immune responses to trigger renal fibrosis
[28]. Treatment with MCE ameliorated renal fibrosis in STZ/
NA-induced mice by reducing the collagen IV synthesis and
fibronectin formation, as demonstrated in our previously
research [22]. In this study, a similar result was shown
(Fig. 3). In addition, the JAK/STAT signaling pathway consti-
tutes one of the primary signaling pathways that regulate
cytokine expression, abnormal matrix synthesis, and has
increasingly been implicated in the pathophysiology of renal
disease [29]. Under MCE treatment, JAK and phosphorylated
STAT3 were reduced in STZ/NA-induced mice significantly.
Earlier studies have reported that protein kinase C (PKC)
enzymes mediated the DN by activating the expression of
NF-kB under oxidative stress [30,31]. In summary, MCE also
could improve the PKC/NF-kB related inflammation in STZ/
NA mice.4. Discussion
A number of diabetes-induced metabolites such as glucose,
PKC, inflammation, oxidative stress and other related factors,racteristics of STZ/NA mice.
/NA STZ/NAþ
1. MCE
STZ/NAþ
1. MCE
STZ/NAþ
2. MCE
4.12** 68.27 ± 5.35*** 45.98 ± 3.79**** 38.79 ± 1.22****
1.05* 16.58 ± 1.97 19.87 ± 1.78*** 23.98 ± 2.03***
12.30* 155.67 ± 14.46 188.89 ± 12.58*** 220.38 ± 13.69***
5.69* 98.94 ± 4.56 110.94 ± 5.65 139.68 ± 9.15***
0.04* 0.53 ± 0.05 0.66 ± 0.03*** 0.80 ± 0.07***
4.31* 43.25 ± 3.21 56.49 ± 5.26*** 68.24 ± 4.92***
GPx¼ glutathione peroxidase; MCE¼Myrciaria cauliflora extract;
determined by Student t test.
oup determined by ANOVA.
Fig. 1 e MCE prevented activation of pro-inflammatory factors in the kidneys of STZ/NA mice. The mRNA expression of
ICAM-1, VCAM-1, MCP-1, CSF-1, TNFa, IL-1b, and IL-6 was analyzed using RT-PCR. * p< 0.001 versus control group; **
p< 0.05, *** p< 0.001 versus STZ/NA group.
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glucose level in diabetic patients is the initial and important
factor. Hyperglycemia raises the oxidative stress by aggra-
vating glucose oxidation and mitochondrial generation of
ROS. Therefore, a high blood glucose level, which causes DNA
damage and contributes to accelerated apoptosis, has been
considered as the key initiator of kidney damage associated
with DN [32]. In the present investigation, symptoms of hy-
perglycemia including increased urine volume and water
consumption, but decreased body weight, were ameliorated
by MCE. MCE also improves the serum biochemical charac-
teristics such as total cholesterol, triglycerides, high density
lipoprotein/low density lipoprotein cholesterol, creatinine,
blood urea nitrogen and insulin level, suggesting that MCE
could control the blood glucose to the normal range therefore
inhibit the renal injury of diabetic mice in the initial stage.
Both oxidative stress and inflammation are important
mediators of the pathogenesis and progression of chronic
kidney disease. Oxidative stress causes inflammation byFig. 2 eMCE reduced the macrophage infiltration in STZ/NAmic
tissues in each group were collected for the detection of macrop
(B). The data were representative of three independent experime
versus STZ/NA group.several mechanisms, including the activation of NF-kB, and
acts in a self-perpetuating cycle. Via production of reactive
oxygen, nitrogen, and halogen species by activated leukocytes
and resident cells, inflammation leads to oxidative stress
successively [33]. In addition, among various signaling ki-
nases, PKC seems to be another centerpiece in the patho-
genesis of DN [34]. The PKC activation decreases nitric oxide
production, increases expression of endothelin-1, and
vascular endothelial growth factor, and then leads to endo-
thelial dysfunction [2]. PKC-b isoforms were preferentially
activated in the retina, kidney and cardiovascular tissues of
diabetic rats [35,36]. Recently, a PKC-b inhibitor has been
suggested by the US Food and Drug Administration for new
drug applications in diabetic retinopathy [25]. Simultaneously,
elevated expression of NF-kB and plasminogen activator
inhibitor-1 induce tissue inflammation and thrombotic
microangiopathy, therefore exacerbate the vascular injury
[37]. The present results demonstrated that MCE ameliorated
renal function in the STZ/NA-induced mice by decreasinge kidney biopsies. The mice were sacrificed, and the kidney
hage infiltration by CD68 staining (400£) (A) and quantified
nts. * p< 0.001 versus control group; ** p< 0.05, *** p< 0.001
Fig. 3 e MCE inhibited the fibrosis and inflammatory protein expression in STZ/NA mice kidney. After the mice were
sacrificed, the protein expression was detected by Western blotting (A) and quantified by densitometry (B). The data were
representative of three independent experiments. * p< 0.05, ** p< 0.001 versus control group; *** p< 0.05, **** p< 0.001
versus STZ/NA group.
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and NF-kB expression.
Anthocyanins are members of the flavonoid group of
phytochemicals with an unsaturated C ring and a hydroxyl at
position 3. Due to the glycosylated structure of polyhydroxy
and polymethoxy derivatives of 2-phenylbenzopyrylium,
acylated or nonacylated with aliphatic acids, phytochemicals
rich in anthocyanins are a rich source of potential therapeutic
agents such as antioxidants. Indeed, many studies have
proved that anthocyanins serve as antioxidants and have
anti-inflammatory properties in metabolic diseases. Experi-
mental evidence and clinical perspectives reveal that antho-
cyanins could prevent or reverse obesity- and Type 2 DM-
related pathologies through a considerable number of mech-
anisms including promotion of antioxidant and anti-
inflammatory activities, improvement of insulin resistance,
and hypolipidemic and hypoglycemic actions [38]. Other re-
searches also showed that anthocyanin-rich bilberry extract
ameliorates hyperglycemia and insulin sensitivity via AMPK
activation in white adipose tissue, skeletal muscle and the
liver in Type 2 diabeticmice [39,40]. Our previous study proved
the main anthocyanins of MCE were delphinidin and cyani-
din. MCE ameliorated the structural and functional abnor-
malities of the diabetic kidney in mice and might be
associatedwith inhibition of Ras regulated renal fibrosis. Here,
we further verified that MCE attenuated diabetes-induced
renal damage via inhibition of oxidative stress and inflam-
matory response. Although MCE could reduce inflammatory
cytokines, decrease macrophage infiltration, and inhibit JAK,
phosphorylated STAT3, PKC-b and NF-kB in STZ/NA mice, thedetailed mechanism needs to be clarified further. With these
benefits, MCE may be used to treat Type 2 diabetes and its
associated renal injury. Our results offer a potent clinical trial
of M. cauliflora extract for the development of an oral hypo-
glycemic agent.Conflicts of interest
The authors declare that they have no competing interests.
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